[Wolman disease].
Tanaka
Akemi
A
Department of Pediatrics, Osaka City University Graduate School of Medicine.
D015217:Cholesterol Ester Storage Disease; D002788:Cholesterol Esters / Q000378:metabolism; D003937:Diagnosis, Differential; D018752:Diet, Fat-Restricted; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008247:Lysosomes / Q000201:enzymology / Q000378:metabolism; D009154:Mutation; D011379:Prognosis; D002787:Sterol Esterase / Q000172:deficiency / Q000235:genetics; D014280:Triglycerides / Q000378:metabolism; D015223:Wolman Disease / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy
D002788:Cholesterol Esters; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D014280:Triglycerides; C503451:LIPA protein, human; D002787:Sterol Esterase